Prakash Pipes Limited (BOM:542684)
India · Delayed Price · Currency is INR 366.70
-8.85 (-2.36%)
At close: Jul 28, 2025
Intercept Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Prakash Pipes had annual revenue of 7.80B INR with 16.60% growth. Prakash Pipes had revenue of 1.83B in the quarter ending March 31, 2025, with 11.07% growth.
Revenue
7.80B
Revenue Growth
+16.60%
P/S Ratio
1.12
Revenue / Employee
16.82M
Employees
464
Market Cap
8.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.80B | 1.11B | 16.60% |
| Mar 31, 2024 | 6.69B | -398.60M | -5.62% |
| Mar 31, 2023 | 7.09B | 924.60M | 14.99% |
| Mar 31, 2022 | 6.17B | 1.41B | 29.53% |
| Mar 31, 2021 | 4.76B | 877.60M | 22.60% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 638.72B |